Recent Finacing
Recent Raise
Rhythm is a Boston-based biotech developing small-peptide therapeutics targeting ghrelin and MC4R pathways, advancing RM-131 for gastroparesis and RM-493 (setmelanotide) for genetic obesity through clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors